Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
Go back to Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update| (NASDAQ: CMPX) | Delayed: 2.10 +0.08 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $ | |||
| Open | $2.04 | 52 Week Low | $ | |||
| Day High | $2.10 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $ | |||
| Volume | 3,389,778 | |||||

